Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue
Go back to Taysha Gene Therapies (TSHA) Misses Q2 EPS by 7c, beats revenue| (NASDAQ: TSHA) | Delayed: 6.53 +0.11 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.42 | 52 Week High | $ | |||
| Open | $6.50 | 52 Week Low | $ | |||
| Day High | $6.70 | P/E | N/A | |||
| Day Low | $6.47 | EPS | $ | |||
| Volume | 2,999,221 | |||||

